| |
| |
|
| Insider
Information: |
Labarre Michael J. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,176 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,369,472 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
168,176 |
|
|
| Total
Value |
$7,369,472 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
|
2024-04-17 |
168,176 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-04-17 |
4 |
AS |
$38.49 |
$384,890 |
D/D |
(10,000) |
168,176 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-04-17 |
4 |
OE |
$8.11 |
$81,100 |
D/D |
10,000 |
178,176 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-04-16 |
4 |
AS |
$38.35 |
$383,500 |
D/D |
(10,000) |
168,176 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-04-16 |
4 |
OE |
$8.11 |
$81,100 |
D/D |
10,000 |
178,176 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-03-26 |
4 |
OE |
$8.11 |
$130,160 |
D/D |
11,618 |
168,176 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-03-13 |
4 |
OE |
$8.11 |
$106,638 |
D/D |
10,000 |
166,558 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-03-13 |
4 |
AS |
$42.27 |
$422,730 |
D/D |
(10,000) |
156,558 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-03-12 |
4 |
AS |
$41.64 |
$416,370 |
D/D |
(10,000) |
156,558 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-03-12 |
4 |
OE |
$12.07 |
$120,700 |
D/D |
10,000 |
166,558 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-28 |
4 |
AS |
$39.54 |
$395,463 |
D/D |
(10,000) |
156,558 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-28 |
4 |
OE |
$8.11 |
$60,590 |
D/D |
7,471 |
164,029 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-27 |
4 |
AS |
$39.95 |
$399,460 |
D/D |
(10,000) |
159,087 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,376 |
171,247 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-16 |
4 |
D |
$36.10 |
$189,778 |
D/D |
(5,257) |
169,087 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-15 |
4 |
D |
$35.91 |
$180,986 |
D/D |
(5,040) |
163,968 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,479 |
167,800 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,386 |
160,529 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,133 |
160,044 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-02-10 |
4 |
D |
$35.49 |
$102,956 |
D/D |
(2,901) |
157,143 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-01-17 |
4 |
OE |
$12.07 |
$120,700 |
D/D |
10,000 |
161,911 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-01-17 |
4 |
AS |
$36.00 |
$360,000 |
D/D |
(10,000) |
151,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-01-16 |
4 |
AS |
$36.00 |
$360,000 |
D/D |
(10,000) |
151,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2024-01-16 |
4 |
OE |
$12.07 |
$120,700 |
D/D |
10,000 |
161,911 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-12-13 |
4 |
AS |
$40.39 |
$403,940 |
D/D |
(10,000) |
151,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-12-13 |
4 |
OE |
$12.07 |
$120,700 |
D/D |
10,000 |
161,911 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
